ArticleBioresources and bioprocessing2025
Light repair effect of polysaccharides component from white Ganoderma lucidum and Laminaria japonica fermentation broth attenuates epidermal barrier dysfunction via TRPV4-Keap-1/Nrf2 pathway.
Article in Bioresources and bioprocessing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Protective effects of Passiflora edulis Sims peel fermentation polysaccharide against UVB-induced photodamage via antioxidant and anti-inflammatory activities.Bioresources and bioprocessing · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Epidermal photoinflammation has emerged as an atypical pathological response that poses a growing global threat to human health and well-being. In this study, a polysaccharide component (named LJGp) was isolated from Laminaria japonica and white Ganoderma lucidum fermentation broth, and its reparative effects on UVB-induced epidermal damage were investigated. LJGp was found to restore the migration ability of HaCaT cells, increase antioxidant enzyme activities, and clear excessive intracellular ROS. At 1500 μg/mL, ROS levels were reduced to about 50% of those in the UVB group, while IL-6 expression decreased to a level comparable with the control group. At the same time, LJGp increased barrier functional proteins, inhibited desmosome degradation, and maintained the stability of the epidermal barrier. Mechanistic results further showed that LJGp regulated the TRPV4-Keap-1/Nrf2 pathway, where UVB-induced TRPV4 activation suppressed Nrf2 activity and promoted AP-1-mediated inflammation. By reducing TRPV4 overexpression and restoring Nrf2 function, LJGp alleviated barrier dysfunction and improved epidermal repair. These results provide supporting data and a scientific basis for the development and utilization of LJGp as an epidermal photoinflammatory relief agent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.